Duzallo is a medication that combines two active ingredients, lesinurad and allopurinol, to effectively treat hyperuricemia in patients with gout. Hyperuricemia is a condition characterized by elevated levels of uric acid in the blood, which can lead to the formation of painful crystals in the joints.
Lesinurad works by increasing the excretion of uric acid through the kidneys, while allopurinol inhibits the production of uric acid in the body. By targeting both the production and excretion of uric acid, Duzallo helps to lower uric acid levels in the blood and prevent the formation of gout crystals.
Patients who have not achieved adequate control of their hyperuricemia with allopurinol alone may benefit from adding Duzallo to their treatment regimen. It is important to follow the dosing instructions provided by your healthcare provider and to monitor your uric acid levels regularly while taking Duzallo.
As with any medication, Duzallo may cause side effects in some patients. Common side effects may include headache, dizziness, and gastrointestinal upset. It is important to report any unusual or severe side effects to your healthcare provider promptly.
Overall, Duzallo is a valuable treatment option for patients with hyperuricemia and gout. By combining the benefits of lesinurad and allopurinol, Duzallo offers a comprehensive approach to managing this chronic condition. If you have any questions or concerns about Duzallo or your gout treatment plan, do not hesitate to speak with your healthcare provider.
EN 
ES 
FR 
PT 
ZH